吴叶林 - 同济大学

个人简介

其研究成果以第一作者或通讯作者发表在 Nature communication, Cancer research, Advanced Science, Angew. Chem. Int. Ed等国际知名杂志中。申请专利3项，授权1项。主持国家自然科学基金青年基金1项，上海市基础项目1项。参与国家及省部级基金项目多项。主要承担的科研项目（项目负责人）国家自然科学基金面上项目1项，基于层状硼化物的糖调控系统用于糖尿病感染创面修复的研究。项目号：82172091，2022.01-2025.12，资助金额55万，主持，在研国自然院内培育面上A类1项，糖尿病创面炎症的功能和机制研究。项目号：04.03.19.104。2020.01-2022.12，资助金额10万，主持，在研上海市基础项目子课题1项，化学动力学疗法的分子生物学功能及机制研究。项目号：19JC1412002。2019.11.01-2022.10.31，资助金额150万，主持，在研院内人才引进项目1项，资助金额30万，主持，在研国家自然科学基金青年项目1项，TLR2调节IL-33抵抗细菌感染的功能和机制研究。项目号：81202327。 2013.1-2015.12，资助金额23万，主持

研究领域

生物医用功能材料在肿瘤和皮肤学领域的应用肿瘤免疫皮肤免疫

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Zhongmin Tang, Shiman Wu, Peiran Zhao, Han Wang, Dalong Ni, Huiyan Li,Xingwu Jiang, Yelin Wu,* Yun Meng, Zhenwei Yao,* Weibo Cai, and Wenbo Bu*.Chemical Factory-guaranteed Enhanced Chemodynamic Therapy for Orthotopic Liver Cancer. Adv. Sci. 2022, 2201232. IF 17.521. (Corresponding author) Yelin Wu, Yanli Li, Guanglei Lv and Wenbo Bu. Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry. DOI: 10.1039/d1sc06315d. Chemical Sci. IF 9.69 Kun Wang, Jinjin Li, Yan Yi, Bin Lv, Yelin Wu*, Chaochao Wang, Huiyan Li, Yanli Li, Yang Liu,a Xuechao Cai, Xianfu Meng, Xingwu Jiang, Xiangpeng Zheng,* Zhaocai Zhou, and Wenbo Bu*. Polyamine-activated carbonyl stress strategy for oxidative damage therapy. Nano Today. 42 (2021) 101355. IF 20.722. (Corresponding author) Fan Wu, Yang Liu, Hui Cheng, Yun Meng, Jieyun Shi, Yang Chen，Yelin Wu*. Enhanced Cancer Starvation Therapy Based on Glucose Oxidase/3-Methyladenine-Loaded Dendritic Mesoporous Organosilicon Nanoparticles. Biomolecules 2021, 11,1363. IF 4.879 Zhenhua Wang, Xiaogang Bao, Junjie Hu, Sibo Shen, Guohua Xu, Yelin Wu*. Nicotinamide Riboside Enhances Endothelial Precursor Cell Function to Promote Refractory Wound Healing Through Mediating the Sirt1/AMPK Pathway. 2021. Front Pharmacol. 2021 May 12; 12:671563. IF 5.81 Yanli Li, Peiran Zhao, Teng Gong*, Han Wang, Xingwu Jiang, Hui Cheng, Yanyan Liu, Yelin Wu*, Wenbo Bu* Redox Dyshomeostasis Strategy for Hypoxic Tumor Therapy Based on DNAzyme‐Loaded Electrophilic ZIFs. 2020. Angew. Chem. Int. Ed. 2020, DOI: 10.1002/anie.202003653. IF 12.124. (Corresponding author) Weiwei Su, Han Wang, Tao Wang, Xiao Li, Zhongmin Tang, Shuai Zhao, Meng Zhang, Danni Li, Xingwu Jiang, Teng Gong, Wei Yang, Changjing Zuo,* Yelin Wu,* Wenbo Bu*. Auger Electrons Constructed Active Sites on Nanocatalysts for Catalytic Internal Radiotherapy. Advanced Science. 2020.7.1903585 . IF 17.521. (Corresponding author) Xianfu Meng, *Yelin Wu, and *Wenbo Bu. Functional CT Contrast Nanoagents for the Tumor Microenvironment. Advanced Healthcare Materials. 2020; 2000912. IF 9.93 (Corresponding author). Yelin Wu, Yanchun Quan, Yuanqi Liu, Keiwei Liu, Hongquan Li, Ziwei Jiang, Tian Zhang, Hu Lei, K atherine A. Radek, Dongqing Li, Zhenhua Wang, Jilong Lu, Wang Wang, Shizhao Ji, Zhaofan Xia, Yuping Lai. Hyperglycemia inhibits REG3A expression to exacerbate TLR3-mediated skin inflammation in diabetes. Nature Communications, 2016 Nov 10; 7:13393. doi: 10.1038/ncomms13393. IF 12.124 Li Qin, Ye-lin Wu, Michael J. Toneff, Dabing Li, Lan Liao, Xiuhua Gao, Jean C-Y. Tien, Yixiang Xu, Zhen Feng, Suoling Zhou, Yi Li, and Jianming Xu. NCOA1 directly targets M-CSF1 expression to promote breast cancer metastasis. Cancer Res. 2014 Jul 25;74(13):3477-88 (Co-first author) Hu Lei, Yue Wang, Tian Zhang, Leilei Chang, *Yelin Wu, *Yuping Lai.TLR3 activation induces S100A7 to regulate keratinocyte differentiation after skin injury. SCIENCE CHINA Life Sciences. 2017 Feb; 60(2):158-167. doi: 10.1007/s11427-016-0027-2. (Corresponding author) Quan Huang, Jian Liu, Tenghui Chen, Lei Li, Lu Wang, *Yelin Wu. Gene expression analysis identifies common and distinct signatures underlying the ductal and lobular breast cancers. The Journal of Reproductive Medicine. 2017; 62:271-283. (Corresponding author) 吴叶林，全艳春，赖玉平. 角质形成细胞与T细胞的crosstalk诱发银屑病的研究现状及展望生命科学Chinese Bulletin of Life Sciences. 2016. Feb. 28(2) 258-267. Wei Xu, Shuang Liu, *Yelin Wu. Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Gent. Mol. Res. 2015 Jun 14(2)7122-7129. (Corresponding author) Ye-Lin Wu, Hongquan Li, Ziwei Jiang, *Lai Y. The interleukin-1 family: a key regulator in the pathogenesis of psoriasis. Austin Journal of Clinical Immunology. Austin Journal of Clinical Immunology. 2014 Nov 17. 1(5) :1-5. Ye-Lin Wu, Jing Huang, Jian Liu, Ming-fei Jin, Mei Gu, Yiguo Hong, Zi-rong Wu. Protective effect of recombinant human glucagons-like peptie-1(rhGLP-1) pretreatment in Streptozotocin-induced diabetic mice. Journal of Peptide Science: 2011 (17) 499-504. Ye-Lin Wu，Jing Huang，Jin Xu，Jian Liu，Zhen Feng，Yang Wang，Yuping Lai，Zi-Rong Wu. Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 toalbumin in serum and prolongs GLP-1 action in vivo. Regulatory Peptides: 2010 (164) 83–89. Miao Xu, Huiping Lu, Young-Hee Lee, Yelin Wu, Kewei Liu, Yuling Shi, Haoran An, Jingren Zhang, Xiaohu Wang, Yeping Lai, Chen Dong. An An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin In?ammation. Immunity: 48(2018)1-12. Lai Y? Li D? Li C? Muhleisen B? Radek KA? Park HJ? Jiang Z? Li Z? Lei H? Quan Y? Zhang T? Wu Y, Kotol P? Morizane S? Hata TR? Iwatsuki K? Tang C? Gallo RL. The antimicrobialprotein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity: 37(2012)74-84.

学术兼职

《中华乳腺病杂志（电子版）》中青年编委上海东方美谷药妆研究院特聘专家